Royalty Pharma plc (RPRX)

NMS – Real Time Price. Currency in USD

59.22

+1.43 (2.47%)

At close: Aug 12, 2026, 3:59 PM EDT

59.14

-0.08 (-0.14%)

After-hours: Aug 12, 2026, 5:27 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

2.38B

2.26B

2.35B

2.24B

Cost of goods sold

-4M

-6M

Gross Profit

2.37B

2.23B

Operating expenses (excl. COGS)

-815M

-971M

-862M

-1.31B

Operating Income

1.56B

1.29B

1.49B

923M

Non-operating income, total

-235M

38M

208M

-693M

Pretax income

1.32B

1.33B

1.70B

230M

Equity in earnings

Taxes

Non-controlling/minority interest

-553M

-472M

-565M

-187M

After tax other income/expense

Net income before discontinued operations

771M

859M

1.13B

43M

Discontinued operations

Net income

771M

859M

1.13B

43M

Dilution adjustment

235M

277M

393M

Preferred dividends

Royalty Pharma plc (RPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Royalty Pharma plc (RPRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Royalty Pharma plc (RPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Royalty Pharma plc (RPRX)

Income Statement (Annual)

Income Statement (Annual)